Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Impella registry analyses report lower mortality than CHIP-BCIS3 in high-risk PCI


FDA grants Priority Review to uniQure’s Huntington’s disease gene therapy


Intranasal foralumab reduces microglial activation in Phase IIa progressive MS trial


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Innovative solutions from Industry 4.0

Presented by Michael May, PhD, President and CEO, CCRM at Centre For Commercialization Of Regenerative Medicine and Philip G. Vanek, PhD, General Manager, Cell and Gene Therapy Strategy at GE
10th June 2019


Sanofi’s Journey & Strategy for Continuous Processing for Small Molecules

Presented by Flavien Susanne, Head of Chemical Development and Engineering at Sanofi and Sean Bermingham, Head of Formulated Products at PSE Ltd
27th September 2021


Accelerating the development of regenerative therapies: Large scale expansion of human mesenchymal stem cells

Presented by Jon Rowley, Ph.D. & Mark Szczypka, Ph.D.
28th March 2017


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia